Treatment of high-grade non-muscle invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations: Results of the phase III clinical trial (NIMBUS)

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGrimm, Marc\\-Oliver
dc.contributor.authorvan der Heijden, Toine
dc.contributor.authorColombel, Marc
dc.contributor.authorMartinez Pineiro, Luis
dc.contributor.authorMuilwijk, Tim
dc.contributor.authorBabjuk, Marek
dc.contributor.authorTurkeri, Levent N.
dc.contributor.authorPalou\\-Redorta, Joan
dc.contributor.authorPatel, Anup
dc.contributor.authorBjartell, Anders
dc.contributor.authorCaris, Christien
dc.contributor.authorSchipper, Raymond
dc.contributor.authorWitjes, Wim
dc.contributor.authorEAU Res Fdn NIMBUS Study Grp
dc.date.accessioned2025-10-16T15:21:51Z
dc.date.issued2020
dc.description.abstractGenitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco, CA, FEB 13-15, 2020
dc.identifier.otherWOS:000529525900465
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7741
dc.publisherLIPPINCOTT WILLIAMS \& WILKINS
dc.sourceJOURNAL OF CLINICAL ONCOLOGY
dc.titleTreatment of high-grade non-muscle invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations: Results of the phase III clinical trial (NIMBUS)
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS